Studies toward the discovery of the next generation of antidepressants.: 3.: Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines

被引:56
作者
Mewshaw, RE [1 ]
Zhou, DH [1 ]
Zhou, P [1 ]
Shi, XJ [1 ]
Hornby, G [1 ]
Spangler, T [1 ]
Scerni, R [1 ]
Smith, D [1 ]
Schechter, LE [1 ]
Andree, TH [1 ]
机构
[1] Wyeth Res, Chem & Screening Sci & Neurosci Discovery Res, Philadelphia, PA 19101 USA
关键词
D O I
10.1021/jm0304010
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
N-Aryloxylethylindolealkylamines (5) having dual 5-HT transporter and 5-HT1A affinity are described. These compounds represent truncated analogues of our previously reported piperidinyl derivatives (3). Compounds in this investigation were found to have more similar affinities and functional activities for the 5-HT1A receptor and 5-HT transporter. Though 5-HT1A antagonism is not consistently observed throughout series 5, several molecular features were found to be essential to obtain high and balanced activities. The proper placement of a heteroatom in the aryl ring and the length of the linkage used to tether the indole moiety had significant influence on 5-HT1A and 5-HT transporter affinities. Introduction of a halogen into the aryl ring usually lowered intrinsic activity and in some cases led to full 5-HT1A antagonists. Compounds 33 and 34 were observed to be full 5-HT1A antagonists with K-i values of approximately 30 nM for the 5-HT1A receptor and K-i values of 5 and 0.5 nM for the 5-HT transporter, respectively. Unfortunately, similar to our previous series (3), compounds in this report also had high affinity for the alpha(1) receptor.
引用
收藏
页码:3823 / 3842
页数:20
相关论文
共 49 条
[1]   SEROTONIN-CONTAINING NEURONS IN BRAIN - DEPRESSION OF FIRING BY MONOAMINE OXIDASE INHIBITORS [J].
AGHAJANIAN, GK ;
GRAHAM, AW ;
SHEARD, MH .
SCIENCE, 1970, 169 (3950) :1100-+
[2]   Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists [J].
Artigas, F ;
Romero, L ;
deMontigny, C ;
Blier, P .
TRENDS IN NEUROSCIENCES, 1996, 19 (09) :378-383
[3]   SELECTIVE SEROTONIN NORADRENALINE REUPTAKE INHIBITORS (SNRIS) - PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN THE TREATMENT OF DEPRESSIVE-DISORDERS [J].
ARTIGAS, F .
CNS DRUGS, 1995, 4 (02) :79-89
[4]   5-HT AND ANTIDEPRESSANTS - NEW VIEWS FROM MICRODIALYSIS STUDIES [J].
ARTIGAS, F .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (07) :262-262
[5]  
BARKER EL, 1994, MOL PHARMACOL, V46, P799
[6]   The use of pindolol with fluoxetine in the treatment of major depression: Final results from a double-blind, placebo-controlled trial [J].
Berman, RM ;
Anand, A ;
Cappiello, A ;
Miller, HL ;
Hu, XS ;
Oren, DA ;
Charney, DS .
BIOLOGICAL PSYCHIATRY, 1999, 45 (09) :1170-1177
[7]   ADVERSE-EFFECTS OF ANTI-DEPRESSANT DRUGS .1. MONOAMINE-OXIDASE INHIBITORS AND TRICYCLICS [J].
BLACKWELL, B .
DRUGS, 1981, 21 (03) :201-219
[8]  
Blier P, 1998, J CLIN PSYCHIAT, V59, P16
[9]   EFFECTIVENESS OF PINDOLOL WITH SELECTED ANTIDEPRESSANT DRUGS IN THE TREATMENT OF MAJOR DEPRESSION [J].
BLIER, P ;
BERGERON, R .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (03) :217-222
[10]  
Briner K, 1998, CURR PHARM DESIGN, V4, P291